Coalition of Over 30 Attorneys Representing Over 1,500 Remdesivir Victims Blast ABC with Cease and Desist Over Dangerous ‘Miracle Cure’ Claim in New “Doctor Odyssey” Show. By Jim Hᴏft (12/21/24)

The coalition’s cease-and-desist letter to ABC demands the immediate removal of content from the pilot episode of ABC’s new medical drama, Doctor Odyssey, which portrays Remdesivir (also marketed as Veklury®) as a “miracle cure.”

Key Points:

  • The demand accuses ABC of promoting remdesivir through misleading and dangerous claims, potentially influencing viewers to trust and pursue treatments that have caused severe harm, including acute kidney injury, liver damage, and even death.

  • November 2020: World Health Organization (WHO) advised against using remdesivir in hospitalized patients, providing evidence that it had little or no effect on mortality or other important outcomes.

  • September 2022: Three California health care providers were sued on grounds they used remdesivir on patients without obtaining informed consent, resulting in the wrongful deaths of several patients.

  • October 2024: The Gateway Pundit ran an exclusive article about a military whistleblower (pseudonym Daniel LeMay) who released “The Remdesivir Papers” report (linked in the “Coalition…” article).

  • Current Lawsuit: Attorneys, led by Jamie Scher, Stephen Scher, and Michael Hamilton, state their clients — many of whom suffered life-altering injuries — were coerced into using Remdesivir under Emergency Use Authorization (EUA) guidelines and denied informed consent due to misinformation and the deliberate withholding of critical risk factors.

    Demands that must be enacted by 12/31/24 to avoid legal action include:

    1. Dub or delete any mentions of remdesivir from Doctor Odyssey.

    2. Disclose any agreements between ABC and Gilead Sciences, remdesivir’s manufacturer.

    3. Establish funds for people who viewed the misleading content and were harmed by remdesivir.

    4. Broadcast an apology across ABC-affiliated stations, warning viewers about remdesivir’s risks.

Dec 22
at
2:44 PM